Isothermal DNA Amplification with Exonuclease-Resistant Primers

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current DNA amplification techniques face challenges with high background signals due to non-target or non-specific amplification reactions, often resulting in false amplification products, especially when target nucleic acids are present in limited quantities, due to contamination from carry-over amplicons, reagents, or laboratory environment contaminants.

Innovation Solution

The use of exonuclease-resistant, inosine-containing primers in conjunction with 5'→3' exonuclease-deficient DNA polymerases and endonucleases capable of nicking inosine-containing strands, along with pre-treatment of amplification solutions with exonucleases to remove contaminating nucleic acids, facilitates specific and efficient DNA amplification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional DNA amplification techniques are used, then amplification efficiency is improved, but background signals and false amplification products increase due to contamination

Engineering Contradiction:
Improveamplification efficiencyVSAvoidspecificity of amplification
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent converts the harmful effect of exonuclease contamination into a beneficial pre-treatment step. By intentionally exposing reagents to exonuclease before amplification, contaminating nucleic acids are degraded while the target DNA (protected by primers) remains intact. This transforms the potential harm of exonuclease activity into a useful decontamination method that improves specificity without sacrificing amplification efficiency

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent applies preliminary decontamination action by treating reagents with exonuclease before the amplification reaction. This pre-treatment step removes contaminating nucleic acids from reagents, preventing them from causing false amplification during the main reaction. The preliminary action ensures that when amplification begins, the reagent environment is clean and specific amplification can proceed efficiently

Inventive Principle:
Principle #10Preliminary action

2Reliability

If pre-amplification sterilization procedures are applied to remove contaminants, then false amplification products are reduced, but amplification efficiency and signal strength may be compromised

Engineering Contradiction:
Improvespecificity of amplificationVSAvoidamplification efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent uses primers as intermediary protective elements. The primers hybridize to the target DNA and physically protect it from exonuclease degradation during the pre-treatment step. This intermediary protection allows the decontamination process to proceed without harming the target template, thereby maintaining amplification efficiency while achieving the desired reduction in false products

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent extracts and removes only the harmful contaminating nucleic acids from the reagent solution through exonuclease treatment, while leaving the essential amplification components (primers, target DNA, polymerase) intact. This selective removal approach maintains amplification efficiency by preserving necessary components while eliminating only the contaminants that cause false products

Inventive Principle:
Principle #2Taking out (Extraction)

3Strength

If exonuclease-resistant primers are used, then resistance to degradation is improved, but cost and complexity of reagent preparation increase

Engineering Contradiction:
Improveresistance to exonuclease degradationVSAvoidcomplexity of reagent preparation
Core Design Contradiction:
StrengthVSDevice complexity

Solution Approach 1:

The patent implements self-service protection where the primer design itself provides the necessary resistance to exonuclease degradation. By incorporating specific sequences or modifications that confer exonuclease resistance, the primers protect themselves during the pre-treatment step without requiring additional protective reagents or complex preparation procedures. This self-protecting mechanism reduces overall system complexity while maintaining the needed resistance

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces non-specific amplification, enhancing the specificity and accuracy of DNA amplification, particularly in scenarios where target DNA is scarce, by effectively removing contaminants and preventing false-positive results.

Implementation Method 1

treating the primer solution with an exonuclease to remove any contaminating nucleic acids

Methodology Applied
Scientific EffectEnzymatic hydrolysis: Hydrolysis

Implementation Method 2

at least one endonuclease that is capable of introducing a nick in a double-stranded DNA sequence comprising an inosine residue at a residue 3' to the inosine residue

Methodology Applied
Scientific EffectPhosphodiester bond cleavage: Hydrolysis

Implementation Method 3

at least one strand displacement DNA polymerase

Methodology Applied
Scientific EffectPhosphodiester bond formation: Chemical Bonding

Data Source

PatentEP3033431B1Endonuclease-assisted isothermal amplification using contamination-free reagents
Publication Date: 2019.10.02 GLOBAL LIFE SCI SOLUTIONS OPERATIONS UK LTD
  • EP3033431B1 patent drawingFigure 1
  • EP3033431B1 patent drawingFigure 2
  • EP3033431B1 patent drawingFigure 3

AI summary

Disclosed are methods and kits for endonuclease-assisted DNA amplification reaction using decontaminated primer solutions that are pre-treated with a nuclease. Nucleic acid amplification assays that employ nuclease-resistant, inosine-containing primers, endonuclease V enzymes to introduce a nick into a target DNA comprising at least one inosine, and a DNA polymerase to generate amplicons of a target DNA are also disclosed.